The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...

It’s National Hot & Spicy Day, and there’s no better place to turn up the heat than Popeyes. Known for its bold Louisiana flavors, Popeyes keeps things simple but satisfying with two main heat levels: ...

Add Yahoo as a preferred source to see more of our stories on Google. It’s National Hot & Spicy Day, and there’s no better place to turn up the heat than Popeyes. Known for its bold Louisiana flavors, ...

Get to know the 2026 Kia K4 trim levels and find out which one offers the best mix of features, performance, and value. The 2026 Kia K4 is one of the most compelling compact sedans made today, ...

Nvidia's biggest gaming reveal at CES 2026 was DLSS 4.5, an update for RTX GPUs that can boost frames rendered by six times via multi-frame generation and sharpen images with an upgraded Transformer ...

The total crypto market cap fell more than 10% in the last 24 hours to $2.8 trillion at the time of writing. Bitcoin (BTC) similarly fell 9% in a day to trade at $83,158.22. In fact, it fell as low as ...

Right now, there are no vehicles for sale in the U.S. that can drive themselves. But automakers are taking steps to reach full automation one day. The cheap health insurance promoted by Trump ...

The phase 2 trial showed that coramitug, an antibody targeting misfolded transthyretin in ATTR-CM, was well tolerated. A dose of 60 mg/kg resulted in a statistically significant reduction in NT-proBNP ...

Background: Elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) levels during the stable phase are associated with poor prognosis in heart failure with preserved ejection fraction (HFpEF).

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

Madrid, Spain – 1 September 2025: In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven ...